Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-03-18 Sale |
2022-03-22 6:39 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
11,859 | $0.6001 | $7,117 | 239,790 (Indirect Direct) |
View |
2021-12-01 Sale |
2021-12-03 5:09 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
50,757 | $0.785 | $39,844 | 264,649 (Indirect Direct) |
View |
2020-11-20 Sale |
2020-11-24 4:29 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
35,000 | $0.4 | $14,000 | 293,148 (Indirect Direct) |
View |
2020-11-18 Sale |
2020-11-20 4:31 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
8,532 | $0.4061 | $3,465 | 328,148 (Indirect Direct) |
View |
2020-09-29 Sale |
2020-10-01 6:33 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
20,000 | $0.8 | $16,000 | 314,423 (Indirect Direct) |
View |
2020-08-18 Sale |
2020-08-20 5:41 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
8,749 | $0.8741 | $7,648 | 334,423 (Indirect Direct) |
View |
2020-05-18 Sale |
2020-05-20 4:09 pm |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
7,734 | $0.5601 | $4,332 | 343,172 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-02-14 5:16 pm |
N/A N/A |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP of Bus. Dev & CBO |
0 | $0 | 251,649 (Indirect) |
View |
2021-12-09 Ownership |
2022-02-14 5:16 pm |
N/A N/A |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP of Bus. Dev & CBO |
13,000 | $0 | 251,649 (Direct) |
View |
2021-02-21 Exercise |
2021-02-23 7:04 pm |
N/A N/A |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
22,258 | $0 | 315,406 (Direct) |
View |
2020-02-21 Ownership |
2021-02-16 7:50 pm |
N/A N/A |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
22,257 | $0 | 315,406 (Direct) |
View |
Ownership |
2021-02-16 7:50 pm |
N/A N/A |
Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer |
0 | $0 | 315,406 (Indirect) |
View |